Developing an Oncology Workforce for the 21st Century

培养 21 世纪的肿瘤学劳动力

• 批准号: 7894004
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 57.16万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-12 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7894004
• 关键词: Academic Training; Award; Back; Chicago; Clinical; Clinical Oncology; Clinical Oncology Supplement (K12); Clinical Research; Communities; Coupled; Doctor of Philosophy; Environment; Fellowship; Genetic; Genomics; Goals; Hand; Health; Individual; Institution; Investigation; Knowledge; Laboratories; Lead; Master of Science; Medicine; Mentors; NCI Scholars Program; Nursing Faculty; Oncologist; Physicians; Preparation; Research; Research Personnel; Research Training; SECTM1 gene; Scientist; Shapes; Structure; Training; Training Programs; Translating; Translational Research; Universities; Work; anticancer research; base; bench to bedside; cancer therapy; career; expectation; experience; next generation; novel therapeutic intervention; oncology; patient oriented research; patient population; programs

DESCRIPTION (provided by applicant): The University of Chicago has long recognized the importance of physician scientists capable of utilizing laboratory discoveries to evolve novel therapeutic approaches and using clinical observations to inform and shape basic investigations. The University has an enviable record of training the next generation of academic oncologists. However, the training of academic leaders with critical expertise in clinical and translational research has become increasingly difficult, mandating the creation of a tightly structured and mentored training environment. Leveraging our current training programs (CTSA, K30 award, non-Roadmap K12 awards, traditional T32 training, K08/K23 mentoring programs), we will create an interdisciplinary program in patient-oriented research to train clinicians and basic scientists to lead interdisciplinary teams that will transform the practice of oncology. The Paul Calabresi K12 Scholars Program is our highly mentored, didactic coursework-intensive program, and "hands on" clinical research training which results in a Master of Science in Health Studies. These scholars are clinical oncologists finishing fellowship training, clinical faculty who wish to change career emphasis, or a scientist with a health-related PhD who wishes to work in the clinical sphere. The strength of our clinical programs coupled with our research intensity and our focus on genetics/genomics research makes the University of Chicago an ideal institution for the preparation of a clinical oncology workforce for the era of personalized medicine. Through this training program will emerge bonafide translational researchers and clinical oncologists who will possess the knowledge and capacity to conduct bench to bedside research and translate their findings back to patients and the population. It is our expectation that individuals completing this program will have obtained the broad research training and comprehensive experience necessary to perform high quality and high impact hypothesis-based clinical and translational research and to make fundamental contributions towards the goal of personalized cancer treatment. An explicit goal of this Paul Calabresi Scholars program, as with all training programs in our institution, is that its training opportunities and benefits will extend far beyond the relatively few scholars whose stipends it will provide. We are confident that the program will reach into the larger oncology trainee community at our University and in Chicago and to young scientists pursuing careers in cancer research all over the globe. Thus, the benefit that accrues from the program's implementation will be substantial.

描述（由申请人提供）：芝加哥大学长期以来一直认识到能够利用实验室发现来发展新的治疗方法并利用临床观察来告知和塑造基础研究的医生科学家的重要性。该大学在培养下一代学术肿瘤学家方面有着令人羡慕的记录。然而，在临床和转化研究中具有关键专业知识的学术领导者的培训变得越来越困难，要求创建一个结构紧凑和指导的培训环境。利用我们目前的培训计划（CTSA，K30奖，非路线图K12奖，传统的T32培训，K 08/K23指导计划），我们将在以患者为导向的研究中创建一个跨学科计划，以培训临床医生和基础科学家领导跨学科团队，改变肿瘤学的实践。保罗卡拉布雷西K12学者计划是我们的高度指导，教学课程密集型计划，和“动手”临床研究培训，导致健康研究理学硕士。这些学者是完成奖学金培训的临床肿瘤学家，希望改变职业重点的临床教师，或希望在临床领域工作的具有健康相关博士学位的科学家。我们的临床项目的实力加上我们的研究强度和我们对遗传学/基因组学研究的关注，使芝加哥大学成为为个性化医疗时代准备临床肿瘤学工作人员的理想机构。通过这个培训计划将出现真正的翻译研究人员和临床肿瘤学家谁将拥有的知识和能力，进行实验室到床边的研究，并将他们的研究结果转化回患者和人口。我们期望完成该计划的个人将获得进行高质量和高影响力的基于假设的临床和转化研究所需的广泛研究培训和综合经验，并为个性化癌症治疗的目标做出根本性贡献。这个保罗·卡拉布雷西学者计划的一个明确目标，与我们机构的所有培训计划一样，是它的培训机会和好处将远远超出它将提供的相对较少的学者。我们相信，该计划将达到更大的肿瘤学实习生社区在我们的大学和芝加哥和年轻的科学家追求职业生涯在癌症研究遍布地球仪。因此，该方案的实施将带来巨大的好处。